Market icon

Flu Hospitalization Rate Week 12, 2026?

Market icon

Flu Hospitalization Rate Week 12, 2026?

Mar 27

Apr 3

Mar 27

Apr 3

90–95 10%

95以上 9.8%

85–90 5.5%

<75 2.5%

Polymarket
NEW

90–95 10%

95以上 9.8%

85–90 5.5%

<75 2.5%

Polymarket
NEW

<75

$145 交易量

2%

75–80

$171 交易量

19%

80–85

$327 交易量

61%

85–90

$158 交易量

24%

90–95

$2,983 交易量

10%

95以上

$110 交易量

10%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

基於Polymarket數據的AI實驗性摘要 · 更新於
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

Trader consensus on Polymarket strongly favors a cumulative flu hospitalization rate of 80–85 per 100,000 population through week 12 (late March) 2026 at 68% implied probability, aligning closely with the median from CDC FluSurv-NET historical data across moderate seasons since 2010, where rates typically range 70–90 by mid-March amid waning winter peaks. This positioning reflects stable epidemiological baselines, with annual severity driven by influenza strain dominance—often A(H3N2)—vaccine matching, and population immunity levels, rather than short-term anomalies. The ongoing 2024–25 season's hospitalization rate has declined sharply to under 2 per 100,000 weekly (cumulative ~50), marking a mild year consistent with good vaccine efficacy but underscoring yearly variability; no major shifts like novel variants have emerged in recent CDC surveillance to alter 2026 forecasts. Watch for WHO's September 2025 northern hemisphere vaccine strain recommendations, which could signal mismatch risks influencing transmission dynamics.

基於Polymarket數據的AI實驗性摘要 · 更新於

警惕外部連結哦。

Frequently Asked Questions

"Flu Hospitalization Rate Week 12, 2026?" is a prediction market on Polymarket with 6 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "80–85" at 61%, followed by "85–90" at 24%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 61¢ implies that the market collectively assigns a 61% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Flu Hospitalization Rate Week 12, 2026?" is a newly created market on Polymarket, launched on Mar 27, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Flu Hospitalization Rate Week 12, 2026?," browse the 6 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Flu Hospitalization Rate Week 12, 2026?" is "80–85" at 61%, meaning the market assigns a 61% chance to that outcome. The next closest outcome is "85–90" at 24%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Flu Hospitalization Rate Week 12, 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.